Immediate Impact
4 hit
Citing Papers
Update οn the diagnosis and management of systemic lupus erythematosus
2020 Hit
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
2019 Hit
Works of Jamal Mikdashi being referenced
Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research
2015